30 related articles for article (PubMed ID: 27511744)
1. Prognostic factors in patients with loco-regionally advanced gastric cancer.
Hultman B; Gunnarsson U; Nygren P; Sundbom M; Glimelius B; Mahteme H
World J Surg Oncol; 2017 Sep; 15(1):172. PubMed ID: 28915886
[TBL] [Abstract][Full Text] [Related]
2. Mesothelin Expression Is a Predictive Factor for Peritoneal Recurrence in Curatively Resected Stage III Gastric Cancer.
Shin SJ; Park S; Kim MH; Nam CM; Kim H; Choi YY; Jung MK; Choi HJ; Rha SY; Chung HC
Oncologist; 2019 Nov; 24(11):e1108-e1114. PubMed ID: 31015316
[TBL] [Abstract][Full Text] [Related]
3. Predicting peritoneal recurrence after radical gastrectomy for gastric cancer: Validation of a prediction model (PERI-Gastric 1 and PERI-Gastric 2) on a Korean database.
Belia F; Kim KY; Agnes A; Park SH; Cho M; Kim YM; Kim HI; Persiani R; D'Ugo D; Biondi A; Hyung WJ
Eur J Surg Oncol; 2024 Jun; 50(6):108359. PubMed ID: 38657377
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemoradiotherapy
Kang WZ; Shi JM; Wang BZ; Xiong JP; Shao XX; Hu HT; Jin J; Tian YT
World J Gastrointest Oncol; 2022 Aug; 14(8):1540-1551. PubMed ID: 36160743
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant SOX chemotherapy versus concurrent chemoradiotherapy after D2 radical resection of locally advanced esophagogastric junction (EGJ) adenocarcinoma: study protocol for a randomized phase III trial (ARTEG).
Shen J; Zhu X; Du Y; Zhu Y; Yu P; Yang L; Xu Z; Huang L; Zhang Y; Zhang Y; Liu L; Cheng X
Trials; 2021 Oct; 22(1):753. PubMed ID: 34717717
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors for Metachronous Isolated Peritoneal Metastasis after Preoperative Chemotherapy and Potentially Curative Gastric Cancer Resection: Results from the CRITICS Trial.
Caspers IA; Sikorska K; Slagter AE; van Amelsfoort RM; Meershoek-Klein Kranenbarg E; van de Velde CJH; Lind P; Nordsmark M; Jansen EPM; Verheij M; van Sandick JW; Cats A; van Grieken NCT
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572852
[TBL] [Abstract][Full Text] [Related]
7. Peritoneal metastasis in gastric cancer: results from the German database.
Rau B; Brandl A; Piso P; Pelz J; Busch P; Demtröder C; Schüle S; Schlitt HJ; Roitman M; Tepel J; Sulkowski U; Uzunoglu F; Hünerbein M; Hörbelt R; Ströhlein M; Beckert S; Königsrainer I; Königsrainer A;
Gastric Cancer; 2020 Jan; 23(1):11-22. PubMed ID: 31228044
[TBL] [Abstract][Full Text] [Related]
8. Dowregulation of OTX1 attenuates gastric cancer cell proliferation, migration and invasion.
Qin SC; Zhao Z; Sheng JX; Xu XH; Yao J; Lu JJ; Chen B; Zhao GD; Wang XY; Yang YD
Oncol Rep; 2018 Oct; 40(4):1907-1916. PubMed ID: 30066897
[TBL] [Abstract][Full Text] [Related]
9. Gastric cancer: D2 dissection or low Maruyama Index-based surgery--a debate.
Douglass HO; Hundahl SA; Macdonald JS; Khatri VP
Surg Oncol Clin N Am; 2007 Jan; 16(1):133-55. PubMed ID: 17336241
[TBL] [Abstract][Full Text] [Related]
10. Advanced gastric cancer: the value of surgery.
Fugazzola P; Ansaloni L; Sartelli M; Catena F; Cicuttin E; Leandro G; De' Angelis GL; Gaiani F; Di Mario F; Tomasoni M; Coccolini F
Acta Biomed; 2018 Dec; 89(8-S):110-116. PubMed ID: 30561428
[TBL] [Abstract][Full Text] [Related]
11. Recursive partition analysis of peritoneal and systemic recurrence in patients with gastric cancer who underwent D2 gastrectomy: Implications for neoadjuvant therapy consideration.
Chang JS; Kim KH; Keum KC; Noh SH; Lim JS; Kim HS; Rha SY; Lee YC; Hyung WJ; Koom WS
J Surg Oncol; 2016 Dec; 114(7):859-864. PubMed ID: 27511744
[TBL] [Abstract][Full Text] [Related]
12. Oncologic outcomes of laparoscopy-assisted distal gastrectomy for gastric cancer.
Fukunaga T; Hiki N; Kubota T; Nunobe S; Tokunaga M; Nohara K; Sano T; Yamaguchi T
Ann Surg Oncol; 2013 Aug; 20(8):2676-82. PubMed ID: 23709054
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for recurrence in T1-2N0 gastric cancer in the United States and China.
Cao L; Selby LV; Hu X; Zhang Y; Janjigian YY; Tang L; Coit DG; Brennan MF; Strong VE
J Surg Oncol; 2016 Jun; 113(7):745-9. PubMed ID: 27040753
[TBL] [Abstract][Full Text] [Related]
14. Locoregional relapse after gastrectomy with D2 lymphadenectomy for gastric cancer.
Chang JS; Kim KH; Yoon HI; Hyung WJ; Rha SY; Kim HS; Lee YC; Lim JS; Noh SH; Koom WS
Br J Surg; 2017 Jun; 104(7):877-884. PubMed ID: 28245053
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors and recurrence pattern in node-negative advanced gastric cancer.
Lee IS; Yook JH; Kim TH; Kim HS; Kim KC; Oh ST; Kim BS
Eur J Surg Oncol; 2013 Feb; 39(2):136-40. PubMed ID: 23148932
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
